Akebia Therapeutics Inc (AKBA)
$0.71 -4.81% Close Oct 30, 2026 Live
Akebia Therapeutics stock today
Akebia Therapeutics closed at $0.71 on October 30, 2026, down 4.81% on the day. Over the past year it returned -66.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $190 million.
$0.50$1.00$1.50$2.00
NovJan 2026MarMayJulSep
| Period | AKBA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -23.2% | -0.9% |
| 3 months | -47.7% | +2.1% |
| Year to date | -56.1% | +11.7% |
| 1 year | -66.4% | +12.4% |
| 3 years | -16.5% | +88.5% |
| 5 years | -75.4% | +76.0% |
Key statistics
- Market value
- $190M
- Price / sales
- 0.9
- 52-week range
- $0.56 to $2.21
- Next report
- Nov 5, 2026
About Akebia Therapeutics
Biopharmaceutical company developing treatments for kidney disease and other conditions.
Sector: Health Care
More on Akebia Therapeutics
- Financials: revenue, earnings and segmentsRevenue +47% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $93.21 today
No forecast, no recommendation. This page describes Akebia Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.